Close this search box.

Taylor Mammon CBD Bought By US Leader Following Three-Year Courtship

LEADING UK CBD firm Taylor Mammon has been bought by premier US operator GenCanna to create one of the world’s major sector players.

Formed in 2018 Taylor Mammon’s co-founder and Managing Director Nathan Wogman says the deal positions it for ‘significant international growth’.

The move culminates ta three-year partnership during which GenCanna has served as Taylor Mammon’s primary source of CBD and other cannabinoids for infusion into brand products.

Taylor Mammon is a white label manufacturer and brand distributor of CBD-infused goods. GenCanna, is a leading producer of hemp-derived, THC-free, premium CBD and other cannabinoids. 

GenCanna CEO Andrew Barnett said: “As one of our long-term and valued customers, we admired Taylor Mammon’s philosophy and approach to CBD.

“This alliance — which we understand is the first of its kind for a UK-based CBD company — drives unique and mutually beneficial operational and marketing synergies that will catapult product development, sales, and revenue opportunities within our respective geographies.” 

The acquisition follows 18-months work by Taylor Mammon to prepare its Novel Foods Application in tandem with GenCanna. 

Related Posts

Related Posts


Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you


Browse by Tags




© 2023 Prohibition Holdings Ltd. All Rights Reserved.


Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?